M. S. Cairo, B. Coiffier, A. Reiter, and A. Younes, Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus, British Journal of Haematology, vol.149, issue.4, pp.578-586, 2010.

S. C. Howard, D. P. Jones, and C. Pui, The Tumor Lysis Syndrome, New England Journal of Medicine, vol.364, issue.19, pp.1844-1854, 2011.

M. B. Davidson, S. Thakkar, J. K. Hix, N. D. Bhandarkar, A. Wong et al., Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome, The American Journal of Medicine, vol.116, issue.8, pp.546-554, 2004.

M. B. Davidson, S. Thakkar, J. K. Hix, N. D. Bhandarkar, A. Wong et al., Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome, The American Journal of Medicine, vol.116, issue.8, pp.546-554, 2004.

N. Hijiya, M. L. Metzger, S. Pounds, J. E. Schmidt, B. I. Razzouk et al., Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemia, Pediatric Blood & Cancer, vol.44, issue.1, pp.63-69, 2004.

H. Dombret, M. Hunault, C. Faucher, M. Dombret, and L. Degos, Acute lysis pneumopathy after chemotherapy for acute myelomonocytic leukemia with abnormal marrow eosinophils, Cancer, vol.69, issue.6, pp.1356-1361, 1992.

T. Suzuki, M. Takeuchi, H. Saeki, S. Yamazaki, H. Koga et al., Super-acute onset of tumor lysis syndrome accompanied by hypercytokinemia during treatment of Hodgkin's lymphoma with ABVD chemotherapy, Clinical Therapeutics, vol.32, issue.3, pp.527-531, 2010.

C. Montalban, F. Liano, and A. Aguilera, Tumour lysis syndrome after treatment of chronic lymphocytic leukaemia with fludarabine., Postgraduate Medical Journal, vol.70, issue.827, pp.651-652, 1994.

M. Soares, G. A. Feres, and J. I. Salluh, Systemic inflammatory response syndrome and multiple organ dysfunction in patients with acute tumor lysis syndrome, Clinics, vol.64, issue.5, pp.479-481, 2009.

A. K. Coutinho, M. D. Santos, H. Pinczowski, O. Feher, and A. Del-giglio, Tumor lysis syndrome in a case of chronic lymphocytic leukemia induced by high-dose corticosteroids, American Journal of Hematology, vol.54, issue.1, pp.85-86, 1997.

E. A. Chubb, D. Maloney, and E. Farley-hills, Tumour lysis syndrome: an unusual presentation, Anaesthesia, vol.65, issue.10, pp.1031-1033, 2010.

G. Zhang, M. Duan, Z. Zhou, J. Yang, and Y. G. Peng, Intraoperative tumor lysis-induced fatal hyperkalemia, Journal of Anesthesia, vol.26, issue.6, pp.945-946, 2012.

I. Moors, F. Pène, É. Lengline, and D. Benoit, Urgent chemotherapy in hematological patients in the ICU, Current Opinion in Critical Care, vol.21, issue.6, p.1, 2015.

C. Créput, L. Galicier, S. Buyse, and E. Azoulay, Understanding organ dysfunction in hemophagocytic lymphohistiocytosis, Intensive Care Medicine, vol.34, issue.7, pp.1177-1187, 2008.

S. Buyse, L. Teixeira, L. Galicier, E. Mariotte, V. Lemiale et al., Critical care management of patients with hemophagocytic lymphohistiocytosis, Intensive Care Medicine, vol.36, issue.10, pp.1695-1702, 2010.

M. Darmon, G. Thiery, M. Ciroldi, S. De-miranda, L. Galicier et al., Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy*, Critical Care Medicine, vol.33, issue.11, pp.2488-2493, 2005.

J. Henter, A. Horne, M. Aricó, R. M. Egeler, A. H. Filipovich et al., HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis, Pediatric Blood & Cancer, vol.48, issue.2, pp.124-131, 2007.

E. J. Gribble, P. V. Sivakumar, R. A. Ponce, and S. D. Hughes, Toxicity as a result of immunostimulation by biologics, Expert Opinion on Drug Metabolism & Toxicology, vol.3, issue.2, pp.209-234, 2007.

D. D. Benoit, P. O. Depuydt, K. H. Vandewoude, F. C. Offner, T. Boterberg et al., Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit, Intensive Care Medicine, vol.32, issue.1, pp.93-99, 2005.

L. Fardet, L. Galicier, O. Lambotte, C. Marzac, C. Aumont et al., Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome, Arthritis & Rheumatology, vol.66, issue.9, pp.2613-2620, 2014.

L. Fardet, L. Galicier, O. Lambotte, C. Marzac, C. Aumont et al., Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome, Arthritis & Rheumatology, vol.66, issue.9, pp.2613-2620, 2014.

S. Ramachandran, F. Zaidi, A. Aggarwal, and R. Gera, Recent advances in diagnostic and therapeutic guidelines for primary and secondary hemophagocytic lymphohistiocytosis, Blood Cells, Molecules, and Diseases, vol.64, pp.53-57, 2017.

G. Dumas, S. Merceron, L. Zafrani, E. Canet, V. Lemiale et al., Syndrome d?hyperviscosité plasmatique, La Revue de Médecine Interne, vol.36, issue.9, pp.588-595, 2015.

G. Dumas, S. Merceron, L. Zafrani, E. Canet, V. Lemiale et al., Syndrome d?hyperviscosité plasmatique, La Revue de Médecine Interne, vol.36, issue.9, pp.588-595, 2015.

G. Dumas, P. Gabarre, N. Bigé, and E. Maury, Hyperviscosity syndrome, Intensive Care Medicine, vol.44, issue.7, pp.1151-1152, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01787150

M. J. Stone and S. A. Bogen, Evidence-based focused review of management of hyperviscosity syndrome, Blood, vol.119, issue.10, pp.2205-2208, 2012.

A. Moreau, E. Lengline, A. Seguin, V. Lemiale, E. Canet et al., Respiratory events at the earliest phase of acute myeloid leukemia, Leukemia & Lymphoma, vol.55, issue.11, pp.2556-2563, 2014.

T. Staudinger and F. Pène, Current insights into severe sepsis in cancer patients, Revista Brasileira de Terapia Intensiva, vol.26, issue.4, pp.335-343, 2014.

E. Azoulay, F. Pène, M. Darmon, E. Lengliné, D. Benoit et al., Managing critically Ill hematology patients: Time to think differently, Blood Reviews, vol.29, issue.6, pp.359-367, 2015.

E. Azoulay, M. Soares, M. Darmon, D. Benoit, S. Pastores et al., Intensive care of the cancer patient: recent achievements and remaining challenges, Annals of Intensive Care, vol.1, issue.1, p.5, 2011.

J. Song, G. Y. Suh, M. P. Chung, H. Kim, O. J. Kwon et al., Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit, Supportive Care in Cancer, vol.19, issue.4, pp.491-495, 2010.

Y. Zerbib, A. Rabbat, M. Fartoukh, N. Bigé, C. Andréjak et al., Urgent Chemotherapy for Life-Threatening Complications Related to Solid Neoplasms, Critical Care Medicine, vol.45, issue.7, pp.e640-e648, 2017.

E. Azoulay, D. Mokart, F. Pène, J. Lambert, A. Kouatchet et al., Outcomes of Critically Ill Patients With Hematologic Malignancies: Prospective Multicenter Data From France and Belgium?A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study, Journal of Clinical Oncology, vol.31, issue.22, pp.2810-2818, 2013.

C. Algrin, S. Faguer, V. Lemiale, E. Lengliné, D. Boutboul et al., Outcomes after intensive care unit admission of patients with newly diagnosed lymphoma, Leukemia & Lymphoma, vol.56, issue.5, pp.1240-1245, 2014.

P. Wohlfarth, T. Staudinger, W. R. Sperr, A. Bojic, O. Robak et al., Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit, Annals of Hematology, vol.93, issue.10, pp.1629-1636, 2014.

A. Lenz, G. A. Franklin, and W. G. Cheadle, Systemic inflammation after trauma, Injury, vol.38, issue.12, pp.1336-1345, 2007.

A. E. Jones, S. Trzeciak, and J. A. Kline, The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation*, Critical Care Medicine, vol.37, issue.5, pp.1649-1654, 2009.

M. Jucker, H. Abts, W. Li, R. Schindler, H. Merz et al., Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease, Blood, vol.77, issue.11, pp.2413-2418, 1991.

S. M. Hsu, S. S. Xie, P. L. Hsu, and J. A. Waldron, Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease, Am J Pathol. juill, vol.141, issue.1, pp.129-167, 1992.

L. Cattaruzza, A. Gloghini, K. Olivo, D. Francia, R. Lorenzon et al., Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma, Int J Cancer. 1 sept, vol.125, issue.5, pp.1481-1490, 1990.

J. D. Griffin, A. Rambaldi, E. Vellenga, D. C. Young, D. Ostapovicz et al., Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors, Blood, vol.70, issue.4, pp.1218-1221, 1987.

Q. Zhang, M. Raoof, Y. Chen, Y. Sumi, T. Sursal et al., Circulating mitochondrial DAMPs cause inflammatory responses to injury, Nature, vol.464, issue.7285, pp.104-107, 2010.

D. Annane, E. Bellissant, and J. Cavaillon, Septic shock, The Lancet, vol.365, issue.9453, pp.63-78, 2005.
URL : https://hal.archives-ouvertes.fr/hal-02159416

R. Dantzer, Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity, European Journal of Pharmacology, vol.500, issue.1-3, pp.399-411, 2004.
URL : https://hal.archives-ouvertes.fr/hal-02676459

P. Matzinger, Tolerance, Danger, and the Extended Family, Annual Review of Immunology, vol.12, issue.1, pp.991-1045, 1994.

C. F. Wenceslau, C. G. Mccarthy, T. Szasz, K. Spitler, S. Goulopoulou et al., Mitochondrial damage-associated molecular patterns and vascular function, European Heart Journal, vol.35, issue.18, pp.1172-1177, 2014.

A. Rubartelli and M. T. Lotze, Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox, Trends in Immunology, vol.28, issue.10, pp.429-436, 2007.

L. G. Sánchez-lozada, T. Nakagawa, D. Kang, D. I. Feig, M. Franco et al., Hormonal and cytokine effects of uric acid, Current Opinion in Nephrology and Hypertension, vol.15, issue.1, pp.30-33, 2006.

C. F. Wenceslau, C. G. Mccarthy, T. Szasz, S. Goulopoulou, and R. C. Webb, Mitochondrial N-formyl peptides induce cardiovascular collapse and sepsis-like syndrome, American Journal of Physiology-Heart and Circulatory Physiology, vol.308, issue.7, pp.H768-H777, 2015.

N. Janus, V. Launay-vacher, G. Deray, A. Thyss, and J. Thariat, Gestion des chimiothérapies chez les patients hémodialysés, Bulletin du Cancer, vol.99, issue.3, pp.371-380, 2012.

I. Yeoman and M. Mars, Robots, men and sex tourism, Futures, vol.44, issue.4, pp.365-371, 2012.

N. Janus and V. Launay-vacher, Pharmacokinetic/pharmacodynamic considerations for cancer patients undergoing hemodialysis, Expert Opinion on Drug Metabolism & Toxicology, vol.13, issue.6, pp.617-623, 2017.

, Annexe 1: Caractéristiques des systèmes éducatifs

. *-score-de-charlson-modifié, avec retrait des items « leucémie » et « lymphome » ** Patient décédé à 24h donc explorations concernant le lymphome non réalisées Légende : LB = lymphome B

, Graphique 12.1. Évolution de la valeur des exportations sectorielles et de la part de la valeur ajoutée sur place dans la valeur des exportations brutes, LT = lymphome T ; xN = nombre de fois la valeur normale Annexe 7 : Article publié dans Critical Care Medicine concernant le choc primaire et l'impact de la chimiothérapie sur son évolution